within Pharmacolibrary.Drugs.ATC.D;

model D08AJ06
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.05,
    Cl             = 0.8 / 1000 / 60,
    adminDuration  = 600,
    adminMass      = 100 / 1000000,
    adminCount     = 1,
    Vd             = 0.0006,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.016666666666666666,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Didecyldimethylammonium chloride is a quaternary ammonium compound used primarily as a disinfectant and antiseptic for topical application to skin and surfaces. It is used in healthcare and industrial settings for its antimicrobial properties but is not approved for systemic pharmaceutical use in humans.</p><h4>Pharmacokinetics</h4><p>No published pharmacokinetic parameters exist for didecyldimethylammonium chloride in humans, as it is not administered systemically; all parameters below are rough estimates for hypothetical topical accidental systemic absorption in a healthy adult.</p><h4>References</h4><ol><li><p>Moghadam, SH, et al., &amp; Foldvari, M (2013). Effect of chemical permeation enhancers on stratum corneum barrier lipid organizational structure and interferon alpha permeability. <i>Molecular pharmaceutics</i> 10(6) 2248â€“2260. DOI:<a href=&quot;https://doi.org/10.1021/mp300441c&quot;>10.1021/mp300441c</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/23587061/&quot;>https://pubmed.ncbi.nlm.nih.gov/23587061</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end D08AJ06;
